Neurxstem, Inc.

Description

Neurxstem delivers the world's first and most advanced synthetic mimic of the human central nervous system (CNS) in a dish. Dr. Rene Anand and Ms. Susan Mckay have developed a Neural Organoid Platform that is a novel, first-in-class system to study human brain disease mechanisms and to provide drug discovery, efficacy, and safety testing. Breakthrough stem cell technology has leap-frogged over the research models of the past to the models of the future. While staggering sums of money have been spent on finding effective treatments for debilitating brain diseases, significant progress has remained elusive. Drugs that are effective in mice against a host of brain diseases including autism, Alzheimer's disease, Parkinson's disease, or brain cancer tragically perform poorly in human patients, where it matters most. With this incredible and powerful model system, no longer do we have to guess whether a treatment will be effective for a human brain disease based on other surrogate models. Neurxstem provides researchers and medical professionals with a human brain template to understand disease mechanisms and discover new treatments before advancing to clinical trials.